Hangzhou Alltest Biotech Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Hangzhou Alltest Biotech Co., Ltd.

Why is Hangzhou Alltest Biotech Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -12.76% and Operating profit at -28.47% over the last 5 years

The company has declared Positive results for the last 4 consecutive quarters

RAW MATERIAL COST(Y) Fallen by -0.76% (YoY)

With ROE of 7.13%, it has a very attractive valuation with a 1.37 Price to Book Value

Over the past year, while the stock has generated a return of -17.29%, its profits have risen by 44.8% ; the PEG ratio of the company is 0.4

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 22.49% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -17.29% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hangzhou Alltest Biotech Co., Ltd. for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Hangzhou Alltest Biotech Co., Ltd.

-37.99%

0.96

29.75%

China Shanghai Composite

16.78%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-8.03%

EBIT Growth (5y)

-31.00%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.64

Sales to Capital Employed (avg)

0.21

Tax Ratio

12.48%

Dividend Payout Ratio

71.47%

Pledged Shares

Institutional Holding

ROCE (avg)

143.79%

ROE (avg)

16.57%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.47

EV to EBIT

-2.94

EV to EBITDA

-2.34

EV to Capital Employed

-0.26

EV to Sales

-0.48

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

3.58%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

INVENTORY TURNOVER RATIO(HY)

Highest at 2.67 times

-36What is not working for the Company

INTEREST(HY)

At CNY 0.26 MM has Grown at 149.77%

PRE-TAX PROFIT(Q)

At CNY 16.14 MM has Fallen at -69.75%

NET PROFIT(Q)

At CNY 14.45 MM has Fallen at -68.62%

OPERATING CASH FLOW(Y)

Lowest at CNY 166.99 MM

ROCE(HY)

Lowest at 4.56%

DEBT-EQUITY RATIO (HY)

Highest at -57.4 %

INTEREST COVERAGE RATIO(Q)

Lowest at 13,880.05

OPERATING PROFIT(Q)

Lowest at CNY 28.7 MM

NET SALES(Q)

Lowest at CNY 195.37 MM

EPS(Q)

Lowest at CNY 0.25

Here's what is working for Hangzhou Alltest Biotech Co., Ltd.

Inventory Turnover Ratio

Highest at 2.67 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Hangzhou Alltest Biotech Co., Ltd.

Interest

At CNY 0.26 MM has Grown at 149.77%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Pre-Tax Profit

At CNY 16.14 MM has Fallen at -69.75%

over average net sales of the previous four periods of CNY 53.36 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 14.45 MM has Fallen at -68.62%

over average net sales of the previous four periods of CNY 46.07 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

At CNY 195.37 MM has Fallen at -13.68%

over average net sales of the previous four periods of CNY 226.34 MM

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Interest Coverage Ratio

Lowest at 13,880.05

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit

Lowest at CNY 28.7 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite negative

Operating Profit (CNY MM)

Debt-Equity Ratio

Highest at -57.4 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow

Lowest at CNY 166.99 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Lowest at CNY 195.37 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

EPS

Lowest at CNY 0.25

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)